Evaluation Of The Efficacy Of The Combination Of GLIZIGEN® Oral Solution 1/Day And Vaginal Gel 1/Night For 2 Months In Patients With Cervical Intraepithelial Neoplasia Grade 1 (LSIL/CIN-1) Caused By High-Risk Human Papillomavirus (HPV-AR)
Condition(s):Papilloma Viral Infection; CIN1; LSIL, Low Grade Squamous Intraepithelial LesionLast Updated:February 7, 2024Recruiting